Subscribe

EAPCI Column

DOI:

EAPCI Focus on the EAPCI Scientific Programme and Congress Committee

What is the role of the committee?

For the 2022-2024 term, my Co-Chair Professor Nicole Karam and I, along with the EAPCI Scientific Programme and Congress Committee members, have defined our goal as serving the unmet educational needs of the interventional community. This was to be achieved by providing platforms for the interventional community to share scientific achievements. We found it also very important to create bridges and links to other subspecialities and European Society of Cardiology (ESC) working groups.

How does the EAPCI Scientific Programme and Congress benefit the interventional cardiologist?

As stated in its name, the EAPCI Scientific Programme and Congress Committee has the task of designing and managing the scientific content of EAPCI events. Above all, this includes EuroPCR, PCR London Valves and EAPCI sessions at the ESC Congress. Beyond this, EAPCI has been present at several national and international congresses and meetings within Europe from Germany to Bulgaria, as well as worldwide from Egypt to China. Our Committee has developed joint sessions with several national cardiac societies, in synergy with EAPCI Young Committee. This has enhanced EAPCI visibility at national level, as well as induced new channels of cooperation.

Parallel to that, our Committee has been responsible for coordinating multiple online events and webinars, which have become available over the year, covering various topics, often in collaboration with other subspecialities.

What has been the biggest achievement of your committee?

I do not believe that we could underline one single big achievement. I would instead emphasise that the Committee kept its main objective continuously in focus and made great efforts to follow its mission. We believe the last two years' term has been a fruitful collaboration of this great team of committee members. This has resulted in development and initiation of great session proposals for the main congresses; EAPCI has started proactively collaborating with national societies all over the globe; and last but not least the webinar catalogue now contains a stunning list of programmes.

How can EAPCI members becoming involved in the work of the Scientific Programmme and Congress Committee?

EAPCI is eager to connect with national societies. This is why we have been present at numerous national meetings in collaboration with local societies. Such connections are mostly initiated by local EAPCI members, who share the idea that such networks are beneficial for both parties, but mostly for the interventional community. Of course, such events are also good platforms to extend the network and to identify future active members of the EAPCI committees.

Volume 20 Number 14
Jul 15, 2024
Volume 20 Number 14
View full issue

Suggested by Cory

Viewpoint

Feb 16, 2026
PCR: a new era dawns
Prendergast B
free

Editorial

10.4244/EIJ-D-25-01330 Feb 16, 2026
Aspirin discontinuation after ACS: timing the transition to ticagrelor monotherapy
Gragnano F and Calabrò P
free

Editorial

10.4244/EIJ-D-25-01331 Feb 16, 2026
Will the dream of "leave nothing behind" remain a utopia if we forget to optimise the systemic medical therapy?
Wykrzykowska J and Kraak R
free

State-of-the-Art

10.4244/EIJ-D-25-00598 Feb 16, 2026
Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisation
Oshima A et al
free

Original Research

10.4244/EIJ-D-25-00618 Feb 16, 2026
Hertz contact intravascular lithotripsy for calcified coronary artery disease: the PINNACLE-I trial
Verheye S et al
open access

Flashlight

10.4244/EIJ-D-25-00431 Feb 16, 2026
A novel spacer for transcatheter treatment of tricuspid regurgitation
Barbieri F et al
open access
Chat with Cory
Hello , I'm Cory and I will do my best to answer your questions about this article. Please remember that this is an experimental feature, and that I'm still learning.
Can you provide a summary of the key findings in this article?
Can you extract and explain the primary hypothesis or research question addressed in this article?
What are the potential clinical applications or implications of the results presented in this paper?
How does this research contribute to our current understanding of cardiovascular disease management?
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved